(Q46225955)

English

Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh

scientific article published on 28 December 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Age-dependent association between IgG2 and IgG3 subclasses to Pf332-C231 antigen and protection from malaria, and induction of protective antibodies by sub-patent malaria infections, in Daraweesh (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

0 references

1 reference

based on heuristic

inferred from title

Marita Troye-Blomberg

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Thor G. Theander

object named as

Thor G Theander

6

0 references

author name string

Hayder A Giha

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Amre Nasr

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Nnaemeka C Iriemenam

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Halima A Balogun

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

David Arnot

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Klavs Berzins

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

Gehad ElGhazali

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

language of work or name

0 references

publication date

28 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

28

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

1732-1739

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

The decline in paediatric malaria admissions on the coast of Kenya

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Declining incidence of malaria imported into the UK from West Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Plasmodium falciparum malaria vaccines in development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

A study of the genomic diversity of Plasmodium falciparum in Senegal 1. Typing by southern blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

The Pf332 gene of Plasmodium falciparum codes for a giant protein that is translocated from the parasite to the membrane of infected erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Functional alteration of red blood cells by a megadalton protein of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Inhibition of in vitro growth of plasmodium falciparum field isolates mediated by human antibodies to Pf155/RESA and Pf332.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Plasmodium falciparum: differential parasite growth inhibition mediated by antibodies to the antigens Pf332 and Pf155/RESA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Analysis of structure and function of the giant protein Pf332 in Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

A malariometric survey in a rural community in the Muheza district, Tanzania: age profiles in the development of humoral immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Humoral response to Plasmodium falciparum Pf155/ring-infected erythrocyte surface antigen and Pf332 in three sympatric ethnic groups of Burkina Faso.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

The epidemiology of febrile malaria episodes in an area of unstable and seasonal transmission

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Eleven years of malaria surveillance in a Sudanese village highlights unexpected variation in individual disease susceptibility and outbreak severity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Dissection of the human antibody response to the malaria antigen Pf155/RESA into epitope specific components

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Fc gamma receptor IIa (CD32) polymorphism and antibody responses to asexual blood-stage antigens of Plasmodium falciparum malaria in Sudanese patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Immunogenicity and antigenic properties of Pf332-C231, a fragment of a non-repeat region of the Plasmodium falciparum antigen Pf332.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Immune effector mechanisms in malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Failure to respond to the surface of Plasmodium falciparum infected erythrocytes predicts susceptibility to clinical malaria amongst African children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Detection of very low level Plasmodium falciparum infections using the nested polymerase chain reaction and a reassessment of the epidemiology of unstable malaria in Sudan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Cerebral malaria is frequently associated with latent parasitemia among the semi-immune population of eastern Sudan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Host age as a determinant of naturally acquired immunity to Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Naturally acquired immunoglobulin (Ig)G subclass antibodies to crude asexual Plasmodium falciparum lysates: evidence for association with protection for IgG1 and disease for IgG2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: Functional role of IgG subclasses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Longitudinal study of Plasmodium falciparum infection and immune responses in infants with or without the sickle cell trait.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.12.018

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.12.018

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/20036751

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46225955&oldid=2100477807"